PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
19-Sep-2025 aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year aap Implantate AG
19-Sep-2025 Biotest AG: Extraordinary general meeting convened at the request of Grifols S.A. Biotest AG
19-Sep-2025 Eckert & Ziegler Gains Approval for GalliaPharm® in Japan Eckert & Ziegler SE
18-Sep-2025 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG
18-Sep-2025 Viromed Medical AG: Successful ISO 13485 certification paves the way for market launch of ViroCAP® in October 2025 Viromed Medical AG
18-Sep-2025 FDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3 Curatis Holding AG
18-Sep-2025 AEVIS VICTORIA SA – Strong growth in revenue in the first half of 2025. Free cash flow exceeds CHF 100 million, enabling debt reduction of more than CHF 120 million.   AEVIS VICTORIA SA
17-Sep-2025 Original-Research: Formycon AG (von First Berlin Equity Research GmbH) Formycon AG
17-Sep-2025 Marinomed Biotech AG announces results for the first half year of 2025 Marinomed Biotech AG
17-Sep-2025 EADV 2025: Almirall advances skin science and leads innovation for holistic patient care in medical dermatology Almirall
17-Sep-2025 Horus Pharma becomes additional commercialization partner for Formycon's Eylea® biosimilar FYB203 in selected European countries under the brand name Baiama® Formycon AG
16-Sep-2025 FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. is to acquire 100 % in stem cell bank “nOvum” spółka z ograniczoną odpowiedzialnością, Warsaw, Poland FamiCord AG
16-Sep-2025 Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 61.607 no-par value bearer shares at an issue price of EUR 17,50 per share Marinomed Biotech AG
16-Sep-2025 Innovative eBPR-GL launched by Vapourtec Vapourtec
16-Sep-2025 aap Implantate AG closes the first half of the year with sales of € 6.2 million; clinical trial nears positive conclusion aap Implantate AG
16-Sep-2025 MPH Health Care AG publishes figures for the first half-year of 2025: Equity (NAV) amounts to EUR 205.1 million, which corresponds to EUR 47.91 per share. The equity ratio fell slightly to 93.7% MPH Health Care AG
16-Sep-2025 Newron presents H1 2025 results and provides business update Newron Pharmaceuticals S.p.A.
15-Sep-2025 Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. Nyxoah SA.
15-Sep-2025 bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Düsseldorf bonyf NV
15-Sep-2025 Curatis: Double-digit growth in core business and development milestone achieved for C-PTBE-01 Curatis Holding AG